H.R. 1’s limits on Medicaid eligibility for certain immigrants -- a provision the National Association of Medicaid Directors head worried hasn't been publicly discussed enough and that beneficiary ...

The deadline for state Medicaid agencies to finalize their decision on whether to participate in the Trump administration’s model testing the ability of "most favored nation” pricing to bring down the ...

The much-anticipated final rule updating requirements for insurers and group health plans to publish negotiated prices has cleared the White House Office of Management and Budget.

CMS significantly scaled back its controversial “most favored nation” drug-pricing demonstration in Medicare Part B, issuing a final rule Wednesday (Sept. 30) that will save $440 million over seven ...

Ranking Senate Finance Committee Democrat Ron Wyden (OR) blasted the administration for draining the $2 billion Medicare Improvement Fund by sending one-time $90 payments, to nearly 21 million seniors ...

A day after HHS Secretary Robert F. Kennedy said the public should trust artificial intelligence over the advice of public health experts on vaccines and other issues, the American Medical Association ...

An FDA draft guidance mostly supported by pharmaceutical lobbies and patient advocacy organizations because of its potential ability to facilitate approvals of rare disease treatments is drawing ...

FDA pledged to be more transparent across a slew of initiatives including progress on the success of animal testing alternatives and evaluation of direct-to-consumer (DTC) advertising in a new report ...

Former Federal Trade Commission Chair Lina Khan clarified her position on a need for federal law to regulate artificial intelligence -- including through mandatory testing and stiff penalties for ...

Anthropic pitched a new health care connector tied to its artificial intelligence model, Claude, to HHS officials at a closed-door meeting Thursday (Oct. 1) the company said could replace humans in ...

FDA is set to consider a new system for heart transplant transportation that aims to extend the lifespan of organs and give surgeons more time to provide transplants.

The Trump administration's "most favored nation" agreements for direct-to-consumer drug prices available through TrumpRx are not always the lowest prices available in comparable countries, a new KFF ...